OA16.05 Trastuzumab Deruxtecan Monotherapy in Pretreated HER2-overexpressing Nonsquamous Non-Small Cell Lung Cancer: DESTINY-Lung03 Part 1

D. Planchard(Université Paris-Saclay), H.R. Kim, T. Suksombooncharoen(Chiang Mai University), Rong Li(St. Luke's Medical Center), J. Samol(Johns Hopkins University), Y. Runglodvatana(Vajira Hospital), Kyung‐Yul Lee(Taipei Medical University-Shuang Ho Hospital), G. C. Chang(Chung Shan Medical University Hospital), D. Kowalski(National Institute of Oncology), Jincheng Han(National Cancer Center), Sharon Saw(National University of Singapore), Y. Huang(National University Cancer Institute, Singapore), A. Sookprasert(Khon Kaen University), Erica C. Nakajima(AstraZeneca (United States)), José Alfón(AstraZeneca (Spain)), Yun-Te Chang(AstraZeneca (United States)), J.C.-H. Yang(National Taiwan University)
Journal of Thoracic Oncology
October 1, 2024
Cited by 9Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis